Listed

DeFi Capital Markets, Inc.: Form 10-Q for the period ended Sep 30, 2023

Filed with the SEC on Nov 20, 2023 and accepted by EDGAR at Nov 20, 2023, 13:48 ET.

Share

Management's discussion and analysis

As filed, 10,772 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As used throughout this Report, “we,” “our,” “the Company” “USI” and similar words refers to Universal Security Instruments, Inc.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains certain forward-looking statements reflecting our current expectations with respect to our operations, performance, financial condition, and other developments. These forward-looking statements may generally be identified by the use of the words “may”, “will”, “believes”, “should”, “expects”, “anticipates”, “estimates”, and similar expressions. These statements are necessarily estimates reflecting management’s best judgment based upon current information and involve a number of risks and uncertainties. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made, and readers are advised that various factors could affect our financial performance and could cause our actual results for future periods to differ materially from those anticipated or projected. While it is impossible to identify all such factors, such factors include, but are not limited to, those risks identified in our periodic reports filed with the Securities and Exchange Commission.

OVERVIEW

We are in the business of marketing and distributing safety and security products. Our financial statements detail our sales and other operational results for the three and six-month periods ended September 30, 2023, and 2022.

The Company has developed products based on new smoke and gas detection technologies, with what the Company believes are improved sensing technology and product features. Most of our new technologies and features have been trademarked under the trade name IoPhic.

Changes in international trade duties and other aspects of international trade policy, both in the U.S. and abroad, could materially impact the cost of our products. All of our products are imported from the Peoples Republic of China (PRC). To date, only certain of our products such as Carbon Monoxide and Photoelectric alarms, and certain wiring devices, have been subjected to tariffs of 25%. We are monitoring these developments and will determine our strategies as additional information becomes available. Any increase in tariffs that is not offset by an increase in our sales prices could have an adverse effect on our business, financial position, results of operations or cash flows.

RESULTS OF OPERATIONS

Three Months Ended September 30, 2023 and 2022

Sales. Net sales for the three months ended September 30, 2023, were $3,717,455 compared to $5,857,141 for the comparable three months in the prior year, a decrease of $2,139,686 (36.5)%. Sales decreased principally due to the timing of orders and delays in both manufacturing, due to supply chain disruptions, and to delays in shipping and handling of containers at California ports of entry. While delays in manufacturing and shipping have improved somewhat over the past fiscal year, we continue to experience significant delays in receiving inventory for sale.

Gross Profit Margin. Gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. Our gross profit margin was 35.2% and 26.7% of sales for the quarters ended September 30, 2023, and 2022, respectively. Gross margins for the three-month period ended September 30, 2023, increased due to variations in the mix of products sold and to continued increases in the cost of certain electronic components. Gross margins were negatively impacted in the period ended September 30, 2022, principally due to increases in the cost of certain electronic components.

Expenses. Selling, general and administrative expenses were $1,334,351 for the three months ended September 30, 2023, compared to $1,189,243 for the comparable three months in the prior year. As a percentage of net sales, these expenses increased to 35.9% for the three-month period ended September 30, 2023, from 20.3% for the 2022 period. These expenses increased as a percentage of net sales principally since selling, general, and administrative expenses do not decrease in direct proportion to a decrease in sales. In addition, during the three months ended September 30, 2023, the Company recorded additional product liability insurance costs as a result of increased sales exposure in the prior fiscal year, while the prior year period included a reduction in salaries expense of approximately $181,000 resulting from recording an employee retention credit under the CARES Act.

Engineering and product development expenses were $131,415 for the three-month period ended September 30, 2023, and $103,245 for the comparable quarter of the prior year, a $28,170 (27.3%) increase. These expenses increased primarily due to additional product development costs.

Interest Expense. Our interest expense was $33,509 for the quarter ended September 30, 2023, compared to interest expense of $68,525 for the quarter ended September 30, 2022. Interest expense is dependent upon the total amounts borrowed from the Factor and changes in interest rates during the period as compared to the corresponding period of the prior year.

Net (Loss) Income. In addition to the differences between the 2023 and 2022 periods discussed above, the Company’s net income for the quarter ended September 30, 2022, included a reduction in salaries expense resulting from recoding an employee retention credit under the CARES Act. For all of the above reasons, we reported a net loss of $186,425 for the quarter ended September 30, 2023, compared to a net income of $200,602 for the corresponding quarter of the prior fiscal year, a $387,027 (192.9%) decrease in net income.

Six Months Ended September 30, 2023 and 2022

Sales. Net sales for the six months ended September 30, 2023, were $10,416,226 compared to $10,492,445 for the comparable six months in the prior period, a decrease of $76,219 (0.7)%. Sales decreased principally due to the timing of orders and delays in both manufacturing, due to supply chain disruptions, and to delays in shipping and handling of containers at California ports of entry. While delays in manufacturing and shipping have improved somewhat over the past fiscal year, we continue to experience significant delays in receiving inventory for sale.

Gross Profit Margin. The gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. The Company’s gross profit margin was 29.0% for the period ended September 30, 2023, and 28.4% for the period ended September 30, 2022. Gross margins are impacted by variations in the mix of products sold and due to continued increases in the cost of certain electronic components.

Expenses. Selling, general and administrative expenses were $2,757,290 for the six months ended September 30, 2023, compared to $2,571,846 for the comparable six months in the prior year. As a percentage of sales, these expenses were 26.5% for the six-month period ended September 30, 2023, and 24.5% for the comparable 2022 period. As a dollar amount these expenses increased by $185,444 principally as a result of recording additional product liability insurance costs due to increased sales exposure in the prior fiscal year.

Engineering and product development expenses were comparable at $196,378 for the six months ended September 30, 2023, to $192,507 for the comparable period of the prior year.

Interest Expense. Our interest expense was $84,005 for the six months ended September 30, 2023, compared to interest expense of $124,021 for the six months ended September 30, 2022. Interest expense is dependent upon the total amounts borrowed from the Factor and changes in interest rates during the period as compared to the corresponding period of the prior year.

Net (Loss) Income. In addition to the differences between the 2023 and 2022 periods discussed above, the Company’s net income for the quarter ended September 30, 2022, included a reduction in salaries expense resulting from recoding an employee retention credit under the CARES Act. For all of the above reasons, we reported a net loss of $21,295 for the six months ended September 30, 2023, compared to a net income of $94,464 for the corresponding period of the prior fiscal year, a decrease in net income of $115,759 (122.5%).

Operating activities provided cash of $650,519 for the six months ended September 30, 2023. This was primarily due to a decrease in accounts receivable and amount due from factor of $534,490, and an increase in accounts payable and accrued expenses and of $1,239,275, and partially offset by an increase in inventories, prepaid expenses of $1,105,053 and a net loss of $21,295. Operating activities used cash of $378,841 for the six months ended September 30, 2022. This was primarily due to an increase in accounts receivable and amount due from factor of $1,276,912 and a decrease in accounts payable and accrued expenses of $177,454 offset by a decrease in inventories and prepaid expenses of $970,998, and net income of $94,464.

There were no investing activities for the six months ended September 30, 2023, or 2022.

Financing activities used cash of $547,203 during the six months ended September 30, 2023, which is comprised of repayments net of borrowings from the factor. Financing activities provided cash of $118,984 during the six months ended September 30, 2022, which is comprised of borrowings net of repayments from the factor of $718,984, and repayment of a note payable to Eyston Company Ltd. of $600,000 for the six months ended September 30, 2022.

Liquidity and Capital Resources

The Company believes its balances of cash, funds available to borrow under the terms of its factoring agreement, and cash generated by ongoing operations will be sufficient to satisfy its cash requirements over the next twelve months and beyond. The Company’s contractual cash requirements have not changed materially since it filed its Form 10-K for the period ended March 31, 2023.

CRITICAL ACCOUNTING POLICIES

In the notes to the consolidated financial statements, and in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Form 10-K, we have disclosed those accounting policies that we consider to be significant in determining our results of Operations and financial condition. There have been no material changes to those policies that we consider to be significant since the filing of our Form 10-K. The accounting principles used in preparing our unaudited condensed consolidated financial statements conform in all material respects to accounting principles generally accepted in the United States of America.

Controls and procedures

As filed, 1,797 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures (as such item is defined in Rules 13a – 15(e) and 15d – 15(e) of the Exchange Act) that is designed to provide reasonable assurance that information, which is required to be disclosed by us in the reports that we file or submit under the Securities and Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and is accumulated and communicated to management in a timely manner. Our Chief Executive Officer and Chief Financial Officer have evaluated this system of disclosure controls and procedures in accordance with applicable Securities and Exchange Commission guidance as of the end of the period covered by this annual report and have concluded that disclosure controls and procedures were not effective.

A material weakness arose in the management review controls over classification of and disclosure of amounts within the financial statements. The Company plans to remediate the material weakness by clarification of the classification of amounts and inclusion of the required disclosures.

A material weakness in the management review controls over the classification of and accounting for income taxes. The Company plans to remediate the material weakness by clarification of the classification of amounts and inclusion of the required disclosures.

Changes in Internal Control over Financial Reporting

There have been no other changes in internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting during the quarter ended September 30, 2023.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-07-01 to 2023-09-30$3.7mus-gaap:Revenues
Revenue6 months2023-04-01 to 2023-09-30$10.4mus-gaap:Revenues
Cost of revenue3 months2023-07-01 to 2023-09-30$2.4mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2023-04-01 to 2023-09-30$7.4mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2023-07-01 to 2023-09-30$1.3mus-gaap:GrossProfit
Gross profit6 months2023-04-01 to 2023-09-30$3.0mus-gaap:GrossProfit
Selling, general and administrative3 months2023-07-01 to 2023-09-30$1.3mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2023-04-01 to 2023-09-30$2.8mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-07-01 to 2023-09-30−$157.6kus-gaap:OperatingIncomeLoss
Operating income6 months2023-04-01 to 2023-09-30$62.7kus-gaap:OperatingIncomeLoss
Interest expense3 months2023-07-01 to 2023-09-30$33.5kus-gaap:InterestExpense
Interest expense6 months2023-04-01 to 2023-09-30$84.0kus-gaap:InterestExpense
Income tax3 months2023-07-01 to 2023-09-30−$4.7kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-07-01 to 2023-09-30−$186.4kus-gaap:NetIncomeLoss
Net income6 months2023-04-01 to 2023-09-30−$21.3kus-gaap:NetIncomeLoss
Diluted EPS3 months2023-07-01 to 2023-09-30−$0.08us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2023-04-01 to 2023-09-30−$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-07-01 to 2023-09-30−$0.08us-gaap:EarningsPerShareBasic
Basic EPS6 months2023-04-01 to 2023-09-30−$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-07-01 to 2023-09-302,312,887 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2023-04-01 to 2023-09-302,312,887 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2023-04-01 to 2023-09-30$650.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2023-09-30$254.8kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-09-30$8.7mus-gaap:AssetsCurrent
Total assetsAt period end2023-09-30$9.0mus-gaap:Assets
Current liabilitiesAt period end2023-09-30$3.6mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2023-09-30$5.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001410578-23-002550. Last ingested by Listed: Nov 4, 2026, 06:09 ET. Listed shows no prices and gives no investment advice.